Development and Assessment of a Novel Ulcerative Colitis–Specific Quality of Life Questionnaire: A Prospective, Multi-Institutional Study
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Interest in the quality of life (QoL) of patients with inflammatory bowel disease (IBD) has recently increased. Although measurement tools have been devised for IBD in general, there is no specific tool for measuring the QoL of patients with ulcerative colitis (UC). Therefore, we developed a QoL questionnaire specifically for patients with UC. Materials and Methods: The Korean Ulcerative Colitis-Specific Questionnaire (K-UCSQ) was developed through item generation, raw-scale construction, focus group meetings, and multi-center field tests. Two hundred patients with UC were recruited for a field test of the K-UCSQ, and subsequent responses to the Inflammatory Bowel Disease Questionnaire (IBDQ) were also obtained. After performing factor analyses to ensure construct validity, the K-UCSQ was finalized as a four-domain, 28-item questionnaire. Subsequent analyses evaluated the reliability of the K-UCSQ in terms of Cronbach’s alpha, concurrent validity in comparison with the pre-established IBDQ, and predictive validity of the area under the ROC curve (AUC) for clinically relevant QoL outcomes. Results: A Cronbach’s alpha of 0.94 showed excellent reliability. Furthermore, correlation analyses demonstrated the concurrent validity of the K-UCSQ in comparison with the IBDQ. The K-UCSQ also showed high validity in predicting the perceived overall health (AUC of 0.812 vs. 0.797 using the IBDQ) and past 2-week QoL (AUC of 0.864 vs. 0.859 using the IBDQ). Conclusion: The newly developed K-UCSQ is concise, bathroom problem-emphasizing, and UC-specific, suggesting that it could be a valid and reliable UC-specific instrument for QoL measurement.
Abstract
Purpose: Interest in the quality of life (QoL) of patients with inflammatory bowel disease (IBD) has recently increased. Although measurement tools have been devised for IBD in general, there is no specific tool for measuring the QoL of patients with ulcerative colitis (UC). Therefore, we developed a QoL questionnaire specifically for patients with UC. Materials and Methods: The Korean Ulcerative Colitis-Specific Questionnaire (K-UCSQ) was developed through item generation, raw-scale construction, focus group meetings, and multi-center field tests. Two hundred patients with UC were recruited for a field test of the K-UCSQ, and subsequent responses to the Inflammatory Bowel Disease Questionnaire (IBDQ) were also obtained. After performing factor analyses to ensure construct validity, the K-UCSQ was finalized as a four-domain, 28-item questionnaire. Subsequent analyses evaluated the reliability of the K-UCSQ in terms of Cronbach’s alpha, concurrent validity in comparison with the pre-established IBDQ, and predictive validity of the area under the ROC curve (AUC) for clinically relevant QoL outcomes. Results: A Cronbach’s alpha of 0.94 showed excellent reliability. Furthermore, correlation analyses demonstrated the concurrent validity of the K-UCSQ in comparison with the IBDQ. The K-UCSQ also showed high validity in predicting the perceived overall health (AUC of 0.812 vs. 0.797 using the IBDQ) and past 2-week QoL (AUC of 0.864 vs. 0.859 using the IBDQ). Conclusion: The newly developed K-UCSQ is concise, bathroom problem-emphasizing, and UC-specific, suggesting that it could be a valid and reliable UC-specific instrument for QoL measurement.
참고문헌 (35)
- Maaser C, "ECCO-ESGAR guideline for diagnostic assessment in IBD part 1 : initial diagnosis, monitoring of known IBD, detection of complications", J Crohns Colitis, 13, pp.144~164 (2019)
- Chang JT, "Pathophysiology of inflammatory bowel diseases", N Engl J Med, 383, pp.2652~2664 (2020)
- Lamb CA, "British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults", Gut, 68(Suppl 3), pp.S1~S106 (2019)
- Turner D, "STRIDE-II : an update on the selecting therapeutic targets in inflammatory bowel disease(STRIDE)initiative of the international organization for the study of IBD(IOIBD) : determining therapeutic goals for treat-to-target strategies in IBD", Gastroenterology, 160, pp.1570~1583 (2021)
- Knowles SR, "Quality of life in inflammatory bowel disease : a systematic review and meta-analyses-part I", Inflamm Bowel Dis, 24, pp.742~751 (2018)
- Keller R, "Quality of life in inflammatory bowel diseases : it is not all about the bowel", Intest Res, 19, pp.45~52 (2021)
- Knowles SR, "Quality of life in inflammatory bowel disease : a systematic review and meta-analyses-part II", Inflamm Bowel Dis, 24, pp.966~976 (2018)
- Yarlas A, "The inflammatory bowel disease questionnaire in randomized controlled trials of treatment for ulcerative colitis : systematic review and meta-analysis", J Patient Cent Res Rev, 7, pp.189~205 (2020)
- Guyatt G, "A new measure of health status for clinical trials in inflammatory bowel disease", Gastroenterology, 96, pp.804~810 (1989)
- Stjernman H, "Evaluation of the inflammatory bowel disease questionnaire in Swedish patients with Crohn's disease", Scand J Gastroenterol, 41, pp.934~943 (2006)
- Kim WH, "Quality of life in Korean patients with inflammatory bowel diseases : ulcerative colitis, Crohn’s disease and intestinal Behçet’s disease", Int J Colorectal Dis, 14, pp.52~57 (1999)
- Rosner B, "Fundamentals of biostatistics", pp.2011, Brooks
- Tabachnick BG, "Using multivariate statistics" (2019), Pearson
- Everitt B, "An introduction to applied multivariate analysis with R" (2011), Springer
- Cronbach LJ, "Coefficient alpha and the internal structure of tests", Psychometrika, 16, pp.297~334 (1951)
- Cho E, "Cronbach’s coefficient alpha : well known but poorly understood", Organ Res Methods, 18, pp.207~230 (2015)
- Maxwell AE, "Comparing the classification of subjects by two independent judges", Br J Psychiatry, 116, pp.651~655 (1970)
- Bhapkar VP, "A note on the equivalence of two test criteria for hypotheses in categorical data", J Am Stat Assoc, 61, pp.228~235 (1966)
- DeLong ER, "Comparing the areas under two or more correlated receiver operating characteristic curves : a nonparametric approach", Biometrics, 44, pp.837~845 (1988)
- Jones JL, "The impact of inflammatory bowel disease in Canada 2018 : quality of life", J Can Assoc Gastroenterol, 2(Suppl 1), pp.S42~S48 (2019)
- Casellas F, "Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease", Eur J Gastroenterol Hepatol, 24, pp.762~769 (2012)
- Vieujean S, "Landscape of new drugs and targets in inflammatory bowel disease", United European Gastroenterol J, 10, pp.1129~1166 (2022)
- Burisch J, "Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study", J Crohns Colitis, 8, pp.1030~1042 (2014)
- Kim B, "Physical activity and quality of life of patients with inflammatory bowel disease", Medicine(Baltimore), 100, pp.e26290~ (2021)
- Rochelle TL, "The importance of illness perceptions, quality of life and psychological status in patients with ulcerative colitis and Crohn’s disease", J Health Psychol, 18, pp.972~983 (2013)
- Engel K, "Newly diagnosed patients with inflammatory bowel disease : the relationship between perceived psychological support, health-related quality of life, and disease activity", Health Equity, 5, pp.42~48 (2021)
- Koh SJ, "Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease", Intest Res, 21, pp.43~60 (2023)
- Na SY, "Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis", Intest Res, 21, pp.61~87 (2023)
- The WHOQOL Group, "Development of the World Health Organization WHOQOL-BREF quality of life assessment", Psychol Med, 28, pp.551~558 (1998)
- Schmidt S, "The EUROHIS-QOL 8-item index : psychometric results of a cross-cultural field study", Eur J Public Health, 16, pp.420~428 (2006)
- Irvine EJ, "The short inflammatory bowel disease questionnaire : a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial", Am J Gastroenterol, 91, pp.1571~1578 (1996)
- Cheung WY, "The UK IBDQ—a British version of the inflammatory bowel disease questionnaire : development and validation", J Clin Epidemiol, 53, pp.297~306 (2000)
- Bodger K, "Development and validation of a rapid, generic measure of disease control from the patient’s perspective : the IBD-control questionnaire", Gut, 63, pp.1092~1102 (2014)
- Alrubaiy L, "Development of a short questionnaire to assess the quality of life in Crohn’s disease and ulcerative colitis", J Crohns Colitis, 9, pp.66~76 (2015)
- Otley A, "The IMPACT questionnaire : a valid measure of health-related quality of life in pediatric inflammatory bowel disease", J Pediatr Gastroenterol Nutr, 35, pp.557~563 (2002)